Follow the Natco Pharma Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Natco Pharma Limited has logged 76 insider filings. Market capitalisation: €166.5bn. The latest transaction was filed on 11 March 2026 (Sale). Among the most active insiders: SATYA VANI NANNAPANENI. All data is openly available.
76
Insider Decl.
n/a
Thresholds
€572,962
28 ops.
Buy Volume
€7m
48 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Natco Pharma Limited Hold (neutral), based on 9 analysts. Average price target: ₹1,021.22.
10Σ signal
Buys €572,962€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,147 of 28,985 companies
80.3
score / 100
Value
73
Quality
87
FCF yld8.3%
Earn yld8.5%
EV/EBITDA10.0x
ROE17%
Gross mgn83%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,563 shares@ ₹1,460.484623.1% of flowEquity SharesSEBI:50ee1589d01fe3ab88b76bdb3d84a4ed4fa23b05
25 of 76 declarations
About Natco Pharma Limited
Natco Pharma Limited is an Indian pharmaceutical company focused on the research, development, and manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.